PubRank

R S Paules

Author PubWeight™ 36.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Assessing gene significance from cDNA microarray expression data via mixed models. J Comput Biol 2001 10.38
2 The human decatenation checkpoint. Proc Natl Acad Sci U S A 2001 1.84
3 Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 2000 1.74
4 Consistency of predictive signature genes and classifiers generated using different microarray platforms. Pharmacogenomics J 2010 1.69
5 DNA damage and cell cycle checkpoints. FASEB J 1996 1.68
6 Blood gene expression signatures predict exposure levels. Proc Natl Acad Sci U S A 2007 1.48
7 Ability of the c-mos product to associate with and phosphorylate tubulin. Science 1991 1.35
8 The Ataxia telangiectasia gene product is required for oxidative stress-induced G1 and G2 checkpoint function in human fibroblasts. J Biol Chem 2001 1.34
9 Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ Health Perspect 1999 1.22
10 A characterization of cytostatic factor activity from Xenopus eggs and c-mos-transformed cells. J Cell Biol 1991 1.21
11 Genomic indicators in the blood predict drug-induced liver injury. Pharmacogenomics J 2010 1.09
12 Inactivation of G2 checkpoint function and chromosomal destabilization are linked in human fibroblasts expressing human papillomavirus type 16 E6. Cell Growth Differ 1997 1.02
13 MAPS: a microarray project system for gene expression experiment information and data validation. Bioinformatics 2001 0.96
14 Attenuation of G2 checkpoint function precedes human cell immortalization. Cancer Res 1995 0.96
15 p21CIP1 is not required for the early G2 checkpoint response to ionizing radiation. Cancer Res 1995 0.95
16 Lack of involvement of ataxia telangiectasia mutated (ATM) in regulation of nuclear factor-kappaB (NF-kappaB) in human diploid fibroblasts. Cancer Res 1999 0.90
17 Differential renal gene expression in prehypertensive and hypertensive spontaneously hypertensive rats. Am J Physiol Renal Physiol 2005 0.87
18 Analysis of genetic and epigenetic mechanisms of toxicity: potential roles of toxicogenomics and proteomics in toxicology. Toxicol Sci 2001 0.84
19 pp39mos is associated with p34cdc2 kinase in c-mosxe-transformed NIH 3T3 cells. Mol Cell Biol 1992 0.81
20 Pheochromocytomas and C-cell thyroid neoplasms in transgenic c-mos mice: a model for the human multiple endocrine neoplasia type 2 syndrome. Cancer Res 1992 0.81
21 Cell survival and changes in gene expression in cells unable to synthesize glutathione. Biofactors 2003 0.80
22 Serum starved v-mos-transformed cells are unable to appropriately downregulate cyclins and CDKs. Oncogene 1997 0.79
23 Quantitation by electron microscopy of the binding of highly specific antibodies to benzo[a]pyrene-DNA adducts. Carcinogenesis 1985 0.77
24 Deregulation of specific E2F complexes by the v-mos oncogene. Oncogene 1997 0.77
25 Molecular mechanisms of environmental carcinogenesis. Environ Health Perspect 1995 0.75
26 Patterns of neoplasia in c-mos transgenic mice and their relevance to multiple endocrine neoplasia. Henry Ford Hosp Med J 1992 0.75
27 v-mos-transformed cells fail to enter quiescence but growth arrest in G1 following serum withdrawal. Exp Cell Res 1994 0.75